<b>Product Review:</b> Equitrac Professional Enterprise Edition v4.63
At a firm the size of Becker & Poliakoff, with more than 110 attorneys dispersed among 15 different offices throughout Florida, plus international and affiliate offices in Europe, the Middle East and China, the willingness to embrace technology and technological innovations has been a proven key to our ability to provide cost effective, high quality legal services to our clients. That's why we were very pleased when Equitrac introduced the latest version (v4.63) of its Equitrac Professional Enterprise Edition. Its ability to automatically synchronize Equitrac's cost-recovery solution with our time-and-billing software made integration seamless and has dramatically improved cost recovery at our firm.
Intelligent e-Discovery Search Practices
As more documentation finds its way into an electronic format, companies must take into account the cost of producing and analyzing them in the discovery process. In particular, firms must address fundamental ways they conduct their pre-trial deliberations to remain in-step with recent judicial rulings and technological advances. <br>Ballooning sets of electronic files bring escalating costs as well as new priorities for managing them.
Features
Methods of Effective Document Selection in Law Firms
The saying "garbage in, garbage out" is often familiar to computer users. It means that computer systems are only as good as the information provided to them. The saying is a reminder of how important proper document selection is for any document retrieval system a firm chooses to deploy.
Features
Implementing Matter-Centric Architectures in Document Management Systems
Several issues face those migrating from traditional document management systems to Matter-Centric Content Management Architectures. This first part of a two-part will series will review some of the key ones for IT professionals.
News Briefs
Highlights of the latest franchising news from around the country.
Features
No Harm to Franchisees When Franchisor Acquires Competitor
It is becoming increasingly common for franchise companies to acquire their competitors. Predictably, the franchisees of the acquired system often will feel threatened and take legal action.
7-Eleven's Development of a New Franchise Agreement: Critique of the Effort and Results ' Recommendations
The first two installments discussed how 7-Eleven, Inc. ("7-Eleven" or the "Company") planned for and developed a new franchise agreement to offer to all of its 3400 franchised stores in the United States. In this final article, we will critique the results by analyzing the final terms and discussing the principal issue that was not resolved to all parties' satisfaction. We will also discuss two important issues that must be resolved in any such undertaking and the Company's approach to them, as well as provide recommendations for future efforts of this nature.
Features
IP News
Highlights of the latest intellectual property news from around the country.
NTP v. RIM: Developments in Infringement Liability Where a Significant Component Is Located Outside the U.S.
Companies involved with technologies that use components located both within and outside the United States will be interested in a recent decision in the patent infringement action brought by NTP, Inc. ("NTP") against Research In Motion, Ltd. ("RIM"). In August 2005, the U.S. Court of Appeals for the Federal Circuit distinguished between infringement of "system" and "method" patent claims in "out of country" situations. The Federal Circuit held that if a component is located outside the United States, a <i>system claim</i> would be infringed if there is beneficial use of the patented system in the United States, while a <i>method claim</i> would not be infringed.
Need Help?
- Prefer an IP authenticated environment? Request a transition or call 800-756-8993.
- Need other assistance? email Customer Service or call 1-877-256-2472.
MOST POPULAR STORIES
- Use of Deferred Prosecution Agreements In White Collar InvestigationsThis article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.Read More ›
- The DOJ's Corporate Enforcement Policy: One Year LaterThe DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.Read More ›
- Surveys in Patent Infringement Litigation: The Next FrontierMost experienced intellectual property attorneys understand the significant role surveys play in trademark infringement and other Lanham Act cases, but relatively few are likely to have considered the use of such research in patent infringement matters. That could soon change in light of the recent admission of a survey into evidence in <i>Applera Corporation, et al. v. MJ Research, Inc., et al.</i>, No. 3:98cv1201 (D. Conn. Aug. 26, 2005). The survey evidence, which showed that 96% of the defendant's customers used its products to perform a patented process, was admitted as evidence in support of a claim of inducement to infringe. The court admitted the survey into evidence over various objections by the defendant, who had argued that the inducement claim could not be proven without the survey.Read More ›
- The DOJ's New Parameters for Evaluating Corporate Compliance ProgramsThe parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.Read More ›
- In the SpotlightOn May 9, 2003, the U.S. Attorney's Office for the District of Massachusetts announced that Bayer Corporation, the pharmaceutical manufacturer, had been sentenced and ordered to pay a criminal fine of $5,590,800 stemming from its earlier plea of guilty to violating the Federal Prescription Drug Marketing Act by failing to list with the FDA its drug product, Cipro, that was privately labeled for an HMO. Such listing is required under the federal Food, Drug & Cosmetic Act. The Federal Prescription Drug Marketing Act, Pub. L. 100-293, enacted on April 22, 1988, as modified on August 26, 1992 by the Prescription Drug Amendments (PDA) Pub. L. 102-353, 106 Stat. 941, amended sections 301, 303, 503, and 801 of the Federal Food, Drug, and Cosmetic Act, codified at 21 U.S.C. '' 331, 333, 353, 381, to establish requirements for distributing prescription drug samples.Read More ›
